Fulgent Genetics, Inc. (FLGT) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Lifestance Health Group, Inc.

Hims & Hers Health, Inc.

Pediatrix Medical Group, Inc.

Addus HomeCare Corp.

RadNet, Inc.

NeoGenomics, Inc.

U.S. Physical Therapy, Inc.

Fulgent Genetics, Inc.

Ginkgo Bioworks Holdings, Inc.

OPKO Health, Inc.

Celldex Therapeutics, Inc.

Why is Fulgent Genetics, Inc. ?

Flat results in Sep 25

INTEREST(HY) At USD 0.04 MM has Grown at 221.43%
OPERATING CASH FLOW(Y) Lowest at USD 1.53 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -3.66%, its profits have risen by 17.8%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -3.66% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Fulgent Genetics, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Fulgent Genetics, Inc.

-1.71%

-0.33

59.56%

S&P 500

13.68%

0.71

19.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

18.49%

EBIT Growth (5y)

-202.15%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.28

Sales to Capital Employed (avg)

0.25

Tax Ratio

15.43%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

67.31%

ROCE (avg)

43.94%

ROE (avg)

17.45%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.41

EV to EBIT

-1.34

EV to EBITDA

-2.04

EV to Capital Employed

0.13

EV to Sales

0.30

PEG Ratio

Dividend Yield

ROCE (Latest)

-9.41%

ROE (Latest)

-3.04%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

NET PROFIT(HY)

Higher at USD -15.64 MM

RAW MATERIAL COST(Y)

Fallen by -15.77% (YoY

NET SALES(Q)

Highest at USD 84.07 MM

OPERATING PROFIT(Q)

Highest at USD -9.31 MM

OPERATING PROFIT MARGIN(Q)

Highest at -11.08 %

PRE-TAX PROFIT(Q)

Highest at USD -7.51 MM

-11What is not working for the Company

INTEREST(HY)

At USD 0.04 MM has Grown at 221.43%

OPERATING CASH FLOW(Y)

Lowest at USD 1.53 MM

Here's what is working for Fulgent Genetics, Inc.

Net Profit

Higher at USD -15.64 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Net Sales

Highest at USD 84.07 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Operating Profit

Highest at USD -9.31 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin

Highest at -11.08 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at USD -7.51 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Raw Material Cost

Fallen by -15.77% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Fulgent Genetics, Inc.

Interest

At USD 0.04 MM has Grown at 221.43%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Cash Flow

Lowest at USD 1.53 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)